Advertisement
Advertisement

DCOY

D

Decoy Therapeutics Inc. Common Stock

5.72
USD
Sponsored
-0.02
-0.35%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

5.95

+0.23
+4.02%

Decoy Therapeutics Inc. Common Stock Profile

About

Decoy Therapeutics Inc. is a preclinical-stage biotechnology company which target serious unmet medical needs. The Company's initial pipeline is focused on respiratory viruses and GI cancers. Decoy Therapeutics Inc., formerly known as Salarius Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Info & Links

CEO

Frederick E. Pierce

Headquarters

2450 Holcombe Blvd., Suite X
Houston, TX 77021, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://decoytx.com/

Auditor

Ernst & Young LLP

Share holders

16

Employees

11

Decoy Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.17M

Enterprise Value

-7.54M

Enterprise Value/EBITDA(ttm)

0.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.54

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-534.45%

Return on Invested Capital(ttm)

-2765.25%

Return on Assets(ttm)

-239.74%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.61M

Net Income Available to Common(ttm)

-12.52M

Diluted EPS(ttm)

-406.89

Share Statistics

Beta (5Y Monthly)

0.37

52-Week Change

--

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

531.97K

Dividend Yield

0.00%

Float4

530.00K

% Held by Insiders

0.30%

% Held by Institutions

11.88%

Balance Sheet

Total Cash(mrq)

10.71M

Total Cash Per Share(mrq)

20.13

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.28%

Quick Ratio(mrq)

2.13%

Book Value Per Share(mrq)

53.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-92.00

Free Cash Flow(ytd)

-3.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement